Acura Pharmaceuticals Inc (ACUR)
0.01
0.00 (0.00%)
USD |
OTCM |
Apr 24, 16:00
Acura Pharmaceuticals Enterprise Value
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| April 24, 2024 | 0.745M |
| April 23, 2024 | 0.745M |
| April 22, 2024 | 0.745M |
| April 19, 2024 | 0.745M |
| April 18, 2024 | 0.2698M |
| April 17, 2024 | 0.2698M |
| April 16, 2024 | 0.2698M |
| April 15, 2024 | 0.2698M |
| April 12, 2024 | 0.2698M |
| April 11, 2024 | 0.2698M |
| April 10, 2024 | 0.2698M |
| April 09, 2024 | 0.2632M |
| April 08, 2024 | 0.2566M |
| April 05, 2024 | 1.405M |
| April 04, 2024 | 1.405M |
| April 03, 2024 | 0.2566M |
| April 02, 2024 | 0.25M |
| April 01, 2024 | 0.25M |
| March 28, 2024 | 0.25M |
| March 27, 2024 | 0.25M |
| March 26, 2024 | 0.25M |
| March 25, 2024 | 0.316M |
| March 22, 2024 | 0.316M |
| March 21, 2024 | 0.316M |
| March 20, 2024 | 0.316M |
| Date | Value |
|---|---|
| March 19, 2024 | 0.316M |
| March 18, 2024 | 0.3622M |
| March 15, 2024 | 0.3622M |
| March 14, 2024 | 0.3622M |
| March 13, 2024 | 0.3622M |
| March 12, 2024 | 0.3622M |
| March 11, 2024 | 0.3622M |
| March 08, 2024 | 0.3622M |
| March 07, 2024 | 0.3622M |
| March 06, 2024 | 0.3622M |
| March 05, 2024 | 0.3622M |
| March 04, 2024 | 0.2962M |
| March 01, 2024 | 0.2236M |
| February 29, 2024 | 0.2236M |
| February 28, 2024 | 0.2236M |
| February 27, 2024 | 0.151M |
| February 26, 2024 | 0.151M |
| February 23, 2024 | 0.2236M |
| February 22, 2024 | 0.2236M |
| February 21, 2024 | 0.151M |
| February 20, 2024 | 0.151M |
| February 16, 2024 | 0.151M |
| February 15, 2024 | 0.151M |
| February 14, 2024 | 0.151M |
| February 13, 2024 | 0.151M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
0.085M
Minimum
Jul 13 2023
54.90M
Maximum
Jun 22 2021
13.22M
Average
11.08M
Median
Sep 01 2020
Enterprise Value Benchmarks
| NovaBay Pharmaceuticals Inc | 2.284M |
| Palatin Technologies Inc | 18.43M |
| iBio Inc | 16.49M |
| Theriva Biologics Inc | -13.90M |
| Oragenics Inc | 3.306M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -0.262M |
| Revenue (Quarterly) | 0.27M |
| Total Expenses (Quarterly) | 0.801M |
| EPS Diluted (Quarterly) | -0.0035 |